T Ring

Summary

Country: Denmark

Publications

  1. ncbi Successful treatment of a patient with primary Sjögren's syndrome with Rituximab
    Troels Ring
    Department of Nephrology, Aalborg Hospital, Hobrovej 18 22, 9100, Aalborg, Denmark
    Clin Rheumatol 25:891-4. 2006
  2. ncbi Clinical review: Renal tubular acidosis--a physicochemical approach
    Troels Ring
    Department of Nephrology, Aalborg Hospital, Aalborg, Denmark
    Crit Care 9:573-80. 2005
  3. ncbi Risk of intracranial aneurysm bleeding in autosomal-dominant polycystic kidney disease
    T Ring
    Department of Nephrology, Aalborg Hospital, Aalborg, Denmark
    Kidney Int 72:1400-2. 2007
  4. ncbi Rituximab induced remission in a patient with Wegener's granulomatosis
    Maria Kallenbach
    Department of Hematology, Aalborg Hospital, Aalborg, Denmark
    Nephron Clin Pract 99:c92-6. 2005
  5. ncbi Comment on "Changes in acid-base balance following bolus infusion of 20% albumin solution in humans" by Bruegger et al
    Troels Ring
    Intensive Care Med 32:480; author reply 481-2. 2006
  6. ncbi Novel OCRL1 mutations in patients with the phenotype of Dent disease
    Boris Utsch
    , , Erlangen, Germany
    Am J Kidney Dis 48:942.e1-14. 2006
  7. ncbi Rituximab in membranous nephropathy
    Troels Ring
    Kidney Int 74:391-2; author reply 392. 2008

Collaborators

  • J A Kellum
  • Boris Utsch
  • Maria Kallenbach
  • Nesrin Besbas
  • Wolfgang Rascher
  • Michael Ludwig
  • Guido Laube
  • Bernd Hoppe
  • Joanna A E van Wijk
  • Ingo Franke
  • Faysal Gok
  • Matti Nuutinen
  • Margarita Neb
  • Fatih Ozaltin
  • Stephanie Karle
  • Marcus R Benz
  • Velibor Tasic
  • Hongmei Duan

Detail Information

Publications7

  1. ncbi Successful treatment of a patient with primary Sjögren's syndrome with Rituximab
    Troels Ring
    Department of Nephrology, Aalborg Hospital, Hobrovej 18 22, 9100, Aalborg, Denmark
    Clin Rheumatol 25:891-4. 2006
    ..Likewise, it may now be possible to separate the immunologic phenomena in Sjögren's syndrome from the consequences of prolonged hyposalivation when studying the pathophysiology of xerostomia...
  2. ncbi Clinical review: Renal tubular acidosis--a physicochemical approach
    Troels Ring
    Department of Nephrology, Aalborg Hospital, Aalborg, Denmark
    Crit Care 9:573-80. 2005
    ..Also, recent evidence from physiology that pH may not regulate acid-base transport is in accordance with the concepts presented by Stewart...
  3. ncbi Risk of intracranial aneurysm bleeding in autosomal-dominant polycystic kidney disease
    T Ring
    Department of Nephrology, Aalborg Hospital, Aalborg, Denmark
    Kidney Int 72:1400-2. 2007
    ..Our results confirm that intracerebral aneurysm bleeding in ADPKD patients tends to cluster in families and that basic family history can provide a simple estimate of family-specific risk...
  4. ncbi Rituximab induced remission in a patient with Wegener's granulomatosis
    Maria Kallenbach
    Department of Hematology, Aalborg Hospital, Aalborg, Denmark
    Nephron Clin Pract 99:c92-6. 2005
    ..There were no side effects to rituximab. CONCLUSION: Rituximab may be effective and seems to be safe in inducing remission in Wegener's granulomatosis. Studies are needed to establish the long-term benefit of this expensive treatment...
  5. ncbi Comment on "Changes in acid-base balance following bolus infusion of 20% albumin solution in humans" by Bruegger et al
    Troels Ring
    Intensive Care Med 32:480; author reply 481-2. 2006
  6. ncbi Novel OCRL1 mutations in patients with the phenotype of Dent disease
    Boris Utsch
    , , Erlangen, Germany
    Am J Kidney Dis 48:942.e1-14. 2006
    ..It remains to be elucidated why the various OCRL1 mutations found in patients with Dent 2 disease do not cause cataracts...
  7. ncbi Rituximab in membranous nephropathy
    Troels Ring
    Kidney Int 74:391-2; author reply 392. 2008